DNAJC19P9

Across TCGA pan-cancer cohorts, DNAJC19P9 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated DNAJC19P9 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher DNAJC19P9 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated DNAJC19P9 expression acts as an unfavorable survival marker, although some lineages such as CESC and BLCA show a favorable association.

CESC, BLCA, and LUSC are the cancer types where DNAJC19P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	III,IV	0.822	0.436	.001	60	view →
BLCA	OS	Tertile	II,III,IV	0.676	0.534	.003	56	view →
LUSC	OS	Median	II,III,IV	0.810	0.672	.004	56	view →
KICH	OS	Median	All	0.921	1.000	.008	35	view →
SKCM	OS	Median	All	0.830	0.729	<.001	24	view →
LGG	DFS	Quartile	All	0.724	0.870	.001	23	view →
LUAD	DFS	Tertile	III,IV	0.290	0.694	.003	22	view →
KIRP	DFS	Tertile	All	0.773	0.942	.001	18	view →
DLBC	DFS	Median	II,III,IV	0.567	0.971	.016	16	view →
PAAD	DFS	Quartile	All	0.303	0.558	.002	14	view →
ESCA	DFS	Median	All	0.402	0.593	.003	12	view →
UCEC	DFS	Median	II,III,IV	0.703	0.273	.019	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

DNAJC19P9–CESC (DFS)

Open the CESC breakdown →